Massachusetts Financial Services’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-291,708
Closed -$14.6M 943
2015
Q1
$14.6M Sell
291,708
-216,710
-43% -$9.1M 0.01% 583
2014
Q4
$17.6M Sell
508,418
-354,937
-41% -$12.4M 0.01% 552
2014
Q3
$28.3M Sell
863,355
-19,498
-2% -$687K 0.02% 461
2014
Q2
$33.9M Buy
882,853
+74,506
+9% +$2.6M 0.02% 433
2014
Q1
$32.1M Sell
808,347
-33,050
-4% -$1.48M 0.02% 425
2013
Q4
$31.4M Buy
841,397
+159,084
+23% +$6.6M 0.02% 418
2013
Q3
$31.1M Buy
682,313
+204,436
+43% +$6.11M 0.02% 403
2013
Q2
$12.9M Buy
+477,877
New +$10.9M 0.01% 507

Other funds holding KYTH

Massachusetts Financial Services's KYTH Position: Q2 2015 in Review

Massachusetts Financial Services sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 291,708 shares — an estimated $14.6M sold.

Massachusetts Financial Services first reported a position in KYTH in Q2 2013 and held it in 8 quarters. The position peaked at $33.9M in Q2 2014. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

  • Massachusetts Financial Services reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
  • Massachusetts Financial Services sold 291,708 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $14.6M.
  • Massachusetts Financial Services first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 8 quarters.
  • Massachusetts Financial Services's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $33.9M in Q2 2014.
  • 153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on Massachusetts Financial Services's 13F filing for Q2 2015, filed 13 Aug 2015.